1. Home
  2. VRAX vs MYSZ Comparison

VRAX vs MYSZ Comparison

Compare VRAX & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • MYSZ
  • Stock Information
  • Founded
  • VRAX 2013
  • MYSZ 1999
  • Country
  • VRAX United Kingdom
  • MYSZ Israel
  • Employees
  • VRAX N/A
  • MYSZ N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MYSZ Computer Software: Prepackaged Software
  • Sector
  • VRAX Health Care
  • MYSZ Technology
  • Exchange
  • VRAX Nasdaq
  • MYSZ Nasdaq
  • Market Cap
  • VRAX 4.7M
  • MYSZ 4.0M
  • IPO Year
  • VRAX 2022
  • MYSZ N/A
  • Fundamental
  • Price
  • VRAX $0.98
  • MYSZ $1.27
  • Analyst Decision
  • VRAX Strong Buy
  • MYSZ Strong Buy
  • Analyst Count
  • VRAX 1
  • MYSZ 1
  • Target Price
  • VRAX $3.00
  • MYSZ $3.00
  • AVG Volume (30 Days)
  • VRAX 64.0K
  • MYSZ 119.6K
  • Earning Date
  • VRAX 02-05-2025
  • MYSZ 05-15-2025
  • Dividend Yield
  • VRAX N/A
  • MYSZ N/A
  • EPS Growth
  • VRAX N/A
  • MYSZ N/A
  • EPS
  • VRAX N/A
  • MYSZ N/A
  • Revenue
  • VRAX $84,872.00
  • MYSZ $6,752,000.00
  • Revenue This Year
  • VRAX $5,169.18
  • MYSZ $29.71
  • Revenue Next Year
  • VRAX $66.97
  • MYSZ N/A
  • P/E Ratio
  • VRAX N/A
  • MYSZ N/A
  • Revenue Growth
  • VRAX 7.03
  • MYSZ N/A
  • 52 Week Low
  • VRAX $0.82
  • MYSZ $1.01
  • 52 Week High
  • VRAX $9.00
  • MYSZ $9.40
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 44.60
  • MYSZ 51.60
  • Support Level
  • VRAX $0.91
  • MYSZ $1.18
  • Resistance Level
  • VRAX $1.03
  • MYSZ $1.34
  • Average True Range (ATR)
  • VRAX 0.08
  • MYSZ 0.09
  • MACD
  • VRAX -0.00
  • MYSZ 0.01
  • Stochastic Oscillator
  • VRAX 24.46
  • MYSZ 65.22

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

Share on Social Networks: